The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Natural History of Chronic Hepatitis B Virus Infection: What We Knew in 1981 and What We Know in 2005
Open accessAbstract
Remarkable progress has been made in our understanding of the natural history of chronic hepatitis B virus (HBV) infection in the past 25 years. Availability of sensitive HBV DNA assays and application of sophisticated immunological techniques led to the recognition that HBV replication persists throughout the course of chronic HBV infection, and host immune response plays a pivotal role in HBV-related liver disease. Knowledge of the HBV genome organization and replication cycle led to the unraveling of HBV genotypes and molecular variants, which contribute to the heterogeneity in outcome of chronic HBV infection. The natural course of chronic HBV infection is now perceived as consisting of 4 phases: immune tolerance, immune clearance [hepatitis B e antigen (HBeAg)-positive chronic hepatitis], inactive carrier state, and reactivation (HBeAg-negative chronic hepatitis B). Understanding the dynamic nature of chronic HBV infection is crucial in the management of HBV carriers and underscores the need for long-term monitoring. Accumulating evidence indicates that antiviral therapy can prevent progression of HBV-related liver disease, particularly among patients with sustained response. Newer antiviral therapies with improved efficacy and decreased risk of resistance may lead to a complete revision of the chapter on the natural history of chronic HBV infection on the occasion of the golden jubilee of HEPATOLOGY.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Summers, J., & Mason, W. S. (1982) · Cell · doi:10.1016/0092-8674(82)90157-x · Cited by 1,443
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B
Marcellin, P., Chang, T.-T., Lim, S. G., Tong, M. J., Sievert, W., Shiffman, M. L., Jeffers, L., Goodman, Z., Wulfsohn, M. S., Xiong, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020681 · Cited by 1,336
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Lu, S.-N., Liaw, Y.-F., You, S.-L., Sun, C.-A., Wang, L.-Y., Hsiao, C. K., Chen, P.-J., Chen, D.-S., & Chen, C.-J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,222
Carman, W. F., Hadziyannis, S., Mcgarvey, M. J., Jacyna, M. R., Karayiannis, P., Makris, A., & Thomas, H. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90713-7 · Cited by 1,200
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Thio, C. L., Seaberg, E. C., Skolasky, R., Phair, J., Visscher, B., Muñoz, A., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11913-1 · Cited by 1,099
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
Kao, J., Chen, P., Lai, M., & Chen, D. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70261-7 · Cited by 925
Rehermann, B., Ferrari, C., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 854
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
Lok, A. S. F., Liang, R. H. S., Chiu, E. K. W., Wong, K.-L., Chan, T.-K., & Todd, D. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90599-g · Cited by 827
Self-citationOkada, K., Kamiyama, I., Inomata, M., Imai, M., Miyakawa, Y., & Mayumi, M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941402 · Cited by 728
Histological outcome during long-term lamivudine therapy
Dienstag, J. L., Goldin, R. D., Heathcote, E. J., Hann, H. W. L., Woessner, M., Stephenson, S. L., Gardner, S., Gray, D. F., & Schiff, E. R. (2003) · Gastroenterology · doi:10.1053/gast.2003.50013 · Cited by 726
Shafritz, D. A., Shouval, D., Sherman, H. I., Hadziyannis, S. J., & Kew, M. C. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110293051807 · Cited by 711
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
Hsu, Y.-S., Chien, R.-N., Yeh, C.-T., Sheen, I.-S., Chiou, H.-Y., Chu, C.-M., & Liaw, Y.-F. (2002) · Hepatology · doi:10.1053/jhep.2002.33638 · Cited by 705
Donato, F. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.323 · Cited by 677
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
Liaw, Y.-F., Tai, D.-I., Chu, C.-M., & Chen, T.-J. (1988) · Hepatology · doi:10.1002/hep.1840080310 · Cited by 612
Brechot, C., Pourcel, C., Louise, A., Rain, B., & Tiollais, P. (1980) · Nature · doi:10.1038/286533a0 · Cited by 612
THE e ANTIGEN AND VERTICAL TRANSMISSION OF HEPATITIS B SURFACE ANTIGEN
BEASLEY, R. P., TREPO, C., STEVENS, C. E., & SZMUNESS, W. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112370 · Cited by 611
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
Yu, M.-W., Yeh, S.-H., Chen, P.-J., Liaw, Y.-F., Lin, C.-L., Liu, C.-J., Shih, W.-L., Kao, J.-H., Chen, D.-S., & Chen, C.-J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji043 · Cited by 569
Hepatitis B e antigen-negative chronic hepatitis B
Hadziyannis, S. J., & Vassilopoulos, D. (2001) · Hepatology · doi:10.1053/jhep.2001.27834 · Cited by 554
Kao, J., Chen, P., Lai, M., & Chen, D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50053 · Cited by 536
Molecular Virology of Hepatitis B Virus
Locarnini, S. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828672 · Cited by 515
Stoop, J. N., van der Molen, R. G., Baan, C. C., van der Laan, L. J. W., Kuipers, E. J., Kusters, J. G., & Janssen, H. L. A. (2005) · Hepatology · doi:10.1002/hep.20649 · Cited by 506
Chu, C., Hussain, M., & Lok, A. S. F. (2002) · Gastroenterology · doi:10.1053/gast.2002.33588 · Cited by 460
Self-citationBenvegnù, L., Gios, M., Boccato, S., & Alberti, A. (2004) · Gut · doi:10.1136/gut.2003.020263 · Cited by 454
Lin, S.-M., Sheen, I.-S., Chien, R.-N., Chu, C.-M., & Liaw, Y.-F. (1999) · Hepatology · doi:10.1002/hep.510290312 · Cited by 444
Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
McMahon, B. J., Holck, P., Bulkow, L., & Snowball, M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00006 · Cited by 431
Chu, C.-M., Karayiannis, P., Fowler, M. J. F., Monjardino, J., Liaw, Y.-F., & Thomas, H. C. (1985) · Hepatology · doi:10.1002/hep.1840050315 · Cited by 419
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
De Jongh, F. E., Janssen, H. L. A., De Man, R. A., Hop, W. C. J., Schalm, S. W., & Van Blankenstein, M. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91188-a · Cited by 418
Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease
Sumi, H., Yokosuka, O., Seki, N., Arai, M., Imazeki, F., Kurihara, T., Kanda, T., Fukai, K., Kato, M., & Saisho, H. (2003) · Hepatology · doi:10.1053/jhep.2003.50036 · Cited by 403
Penna, A., Chisari, F. V., Bertoletti, A., Missale, G., Fowler, P., Giuberti, T., Fiaccadori, F., & Ferrari, C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1565 · Cited by 365
Funk, M. L., Rosenberg, D. M., & Lok, A. S. F. (2002) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2002.00304.x · Cited by 354
Self-citationLiaw, Y.-F., Chu, C.-M., Su, I.-J., Huang, M.-J., Lin, D.-Y., & Chang-Chien, C.-S. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80114-0 · Cited by 341
Brechot, C., Scotto, J., Charnay, P., Hadchouel, M., Degos, F., Trepo, C., & Tiollais, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90182-3 · Cited by 334
Fattovich, G. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05474-6 · Cited by 333
Brunetto, M. R., Oliveri, F., Coco, B., Leandro, G., Colombatto, P., Gorin, J. M., & Bonino, F. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00266-5 · Cited by 331
Lok, A. S. F., Lai, C.-L., Wu, P.-C., Leung, E. K. Y., & Lam, T.-S. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90613-5 · Cited by 326
Self-citationChen, Y., Sheen, I. –., Chu, C., & Liaw, Y. (2002) · Gastroenterology · doi:10.1053/gast.2002.36026 · Cited by 325
Incidence of Hepatitis B Virus Infections in Preschool Children in Taiwan
Beasley, R. P., Hwang, L.-Y., Lin, C.-C., Leu, M.-L., Stevens, C. E., Szmuness, W., & Chen, K.-P. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/146.2.198 · Cited by 320
Lai, C., Rosmawati, M., Lao, J., Van Vlierberghe, H., Anderson, F. H., Thomas, N., & Dehertogh, D. (2002) · Gastroenterology · doi:10.1053/gast.2002.37058 · Cited by 302
Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection
Chu, C.-J., Hussain, M., & Lok, A. S. F. (2002) · Hepatology · doi:10.1002/hep.1840360617 · Cited by 295
Self-citationChu, C., Hung, S.-J., Lin, J., Tai, D., & Liaw, Y. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.12.040 · Cited by 287
Tsai, S. L., Chen, P. J., Lai, M. Y., Yang, P. M., Sung, J. L., Huang, J. H., Hwang, L. H., Chang, T. H., & Chen, D. S. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115590 · Cited by 287
Yuan, J., Govindarajan, S., Arakawa, K., & Yu, M. C. (2004) · Cancer · doi:10.1002/cncr.20427 · Cited by 275
Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults
Tassopoulos, N. C., Papaevangelou, G. J., Sjogren, M. H., Roumeliotou-karayannis, A., Gerin, J. L., & Purcell, R. H. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90614-7 · Cited by 271
Natural history of chronic HBV carriers in northern Italy: Morbidity and mortality after 30 years
Manno, M., Cammà, C., Schepis, F., Bassi, F., Gelmini, R., Giannini, F., Miselli, F., Grottola, A., Ferretti, I., Vecchi, C., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.021 · Cited by 256
Sherlock, S., Niazi, S. P., Fox, R. A., & Scheuer, P. J. (1970) · The Lancet · doi:10.1016/s0140-6736(70)91737-x · Cited by 252
Huo, T.-I., Wu, J.-C., Lee, P.-C., Chau, G.-Y., Lui, W.-Y., Tsay, S.-H., Ting, L.-T., Chang, F.-Y., & Lee, S.-D. (1998) · Hepatology · doi:10.1002/hep.510280130 · Cited by 249
Liaw, Y.-F., Chen, Y.-C., Sheen, I.-S., Chien, R.-N., Yeh, C.-T., & Chu, C.-M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.011 · Cited by 243
Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection
Lok, A. S. F., & Lai, C.-L. (1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90069-4 · Cited by 238
Self-citationFamilial Risk of Hepatocellular Carcinoma Among Chronic Hepatitis B Carriers and Their Relatives
Yu, M.-W. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1159 · Cited by 235
Yuen, M.-F., Hui, C.-K., Cheng, C.-C., Wu, C.-H., Lai, Y.-P., & Lai, C.-L. (2001) · Hepatology · doi:10.1053/jhep.2001.25273 · Cited by 232
Viral hepatitis: clinical aspects
REDEKER, A. G. (1975) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197507000-00003 · Cited by 183
Long–Term Histologic and Virologic Outcomes of Acute Self–Limited Hepatitis B
Yuki, N., Nagaoka, T., Yamashiro, M., Mochizuki, K., Kaneko, A., Yamamoto, K., Omura, M., Hikiji, K., & Kato, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50171 · Cited by 182
Kao, J., Chen, P., Lai, M., & Chen, D. (2004) · Journal of Medical Virology · doi:10.1002/jmv.10534 · Cited by 170
Ohnishi, K., Iida, S., Iwama, S., Goto, N., Nomura, F., Takashi, M., 昭彦, 三., Kono, K., Kimura, K., 広隆, 武., et al. (1982) · Cancer · Cited by 164
Kato, Y., Nakata, K., Nagataki, S., Omagari, K., FURUKAWA, R., KUSUMOTO, Y., Mori, I., TAJIMA, H., Tanioka, H., & Yano, M. (1994) · Cancer · doi:10.1002/1097-0142(19941015)74:8<2234::aid-cncr2820740805>3.0.co;2-6 · Cited by 157
Bläckberg, J., & Kidd‐Ljunggren, K. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80134-8 · Cited by 154
Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis
Sheen, I., Liaw, Y., Tai, D., & Chu, C. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90566-9 · Cited by 138
Sampliner, R. E., Hamilton, F. A., Iseri, O. A., Tabor, E., & Boitnott, J. (1979) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197901000-00002 · Cited by 120
RELATION BETWEEN AFLATOXIN, HEPATITIS-B VIRUS, AND HEPATOCELLULAR CARCINOMA
Lutwick, L. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91210-8 · Cited by 105
Tang, B., Kruger, W. D., Chen, G., Shen, F., Lin, W. Y., Mboup, S., London, W. T., & Evans, A. A. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10559 · Cited by 88
Interferon-α for HBeAg-positive chronic hepatitis B
Craxı̀, A., Bona, D. D., & Cammà, C. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00154-5 · Cited by 81
Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B
Rizzetto, M., Tassopoulos, N. C., Goldin, R. D., Esteban, R., Santantonio, T. A., Heathcote, E. J., Lagget, M., Taak, N. K., Woessner, M. A., & Gardner, S. D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.006 · Cited by 80
Primary hepatocellular carcinoma in alaskan natives, 1969–1979
Heyward, W. L., Lanier, A. P., Bender, T. R., Hardison, H. H., Dohan, P. H., McMahon, B. J., & Francis, D. P. (1981) · International Journal of Cancer · doi:10.1002/ijc.2910280109 · Cited by 38
Cited by
Lok, A. S. F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,087
Self-citationChronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Self-citationAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
AASLD guidelines for treatment of chronic hepatitis B
Terrault, N. A., Bzowej, N. H., Chang, K., Hwang, J. P., Jonas, M. M., & Murad, M. H. (2016) · Hepatology · doi:10.1002/hep.28156 · Cited by 2,006
Dienstag, J. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801644 · Cited by 961
Metadata
- Authors
- Yim, H. J., & Lok, A. S.-F.
- Venue
- Hepatology
- Published
- 2006-02
- Volume
- 43
- Issue
- Supplement 1
- Pages
- S173-S181
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1985670796
- Cited by
- 545
- References
- 67
- FWCI
- 27.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.